mylan is a global pharmaceutical company committed to setting new standards in healthcare. working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. we offer a growing portfolio of around 1,400 generic pharmaceuticals and several brand medications. in addition, we offer a wide range of antiretroviral therapies, upon which nearly 50% of hiv/aids patients in developing countries depend. we also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in about 145 countries and territories. our workforce of approximately 30,000 people is dedicated to creating better health for a better world, one person at a time. learn more at mylan.com.
Financial Statements
- Click here to download Viatris Inc's Income Statement
- Click here to download Viatris Inc's Balance Sheet
- Click here to download Viatris Inc's Statement of Cash Flows
Key Info
- Industry: Pharmaceutical Preparation Manufacturing
- Sector: Manufacturing
- CEO Name: Michael Goettler
Key Statistics
- Stock Price: $10.75
- Dividend Yield: 4.3%
- Market Capitalization: $13,194,857,445
- Shares Outstanding: 1,199,532,495
- Number of Employees: 12,348
- Trailing 12-Month EPS: $1.53
- Trailing 12-Month DPS: $0.47
- Payout Ratio: 30.7%
Important Dates
- Next Earnings Date: 2023-11-06
- Next Ex-Dividend Date: 2023-08-23
Price Trends
- Current Stock Price: $10.75
- 52-week high: $11.82
- 52-week low: $7.94
- 200-day moving average: $9.87
- 50-day moving average: $10.67
Performance
- 1-Month Price Return: 6.9%
- 3-Month Price Return: 21.1%
- 6-Month Price Return: 3.0%
- 1-Year Price Return: 20.2%
- 2-Year Price Return: -15.9%
- 5-Year Price Return: -24.7%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast